Related Experiment Video
Updated: Jan 25, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Platelet to Lymphocyte Ratio in Cardiovascular Diseases: A Systematic Review
Alparslan Kurtul1, Ender Ornek2
11 Cardiology Department, Tayfur Ata Sokmen Faculty of Medicine, Hatay Mustafa Kemal University, Hatay, Antakya, Turkey.
Insights
The platelet-to-lymphocyte ratio (PLR) is a simple blood test marker. High PLR is linked to worse outcomes in cardiovascular diseases, suggesting its prognostic value.
Area of Science:
- Cardiology
- Hematology
- Systemic Inflammation
Background:
- The platelet-to-lymphocyte ratio (PLR) integrates thrombotic and inflammatory pathways.
- Initially used for cancer prognosis, PLR is now explored as a cardiovascular biomarker.
Purpose of the Study:
- To review evidence on the association between PLR and cardiovascular disease (CVD).
- To evaluate PLR's potential as a prognostic marker for CVD outcomes.
Main Methods:
- Systematic review of clinical trials indexed in PubMed, EMBASE, and Web of Science.
- Data up to April 18, 2018, was assessed for PLR's association with mortality and major adverse cardiac events.
Main Results:
- Most studies reviewed reported significant associations between elevated PLR and adverse outcomes in various cardiovascular conditions.
- A high PLR was consistently linked to poorer prognoses in patients with CVD.
Conclusions:
- The platelet-to-lymphocyte ratio (PLR) is an accessible and cost-effective marker of systemic inflammation.
- PLR demonstrates potential as a valuable prognostic tool for predicting outcomes across different types of cardiovascular disease.
Abstract:
The platelet to lymphocyte ratio (PLR) is an integrated reflection of 2 opposite thrombotic/inflammatory pathways that are easily calculated from a complete blood count. The PLR initially served as a systemic inflammatory biomarker to predict the prognosis of neoplastic diseases. In recent years, the PLR has been used as a prognostic marker in cardiovascular (CV) conditions. In this review, we consider the evidence regarding the association of the PLR with CV disease (CVD) and its possible use as a prognostic marker of CVD. The role of PLR has been investigated in CV conditions in several studies. We assessed clinical trials using PubMed, EMBASE, and Web of Science (up to April 18, 2018) to evaluate the association between PLR and mortality/major adverse cardiac events in these conditions. Most of these studies reported significant relationships between a high PLR and diverse outcomes. In conclusion, we suggest that PLR is a cheap and easily available systemic inflammatory marker that can predict distinct outcomes in different types of CVD.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Odds Ratio

